June 2020

12

Jun

Biofortuna appointed as CMO for QuantuMDx CE–marked assay

By admin.bio No comments yet

Biofortuna has provided assay development and manufacturing support to QuantuMDx Group Limited to assist in the manufacturing scale-up, regulatory approval and launch of their rapid, sensitive SARS-CoV-2 test.

Biofortuna is a contract development and manufacturing organisation providing genomic services, custom development and manufacturing support.

Operating from state-of-the art, humidity-controlled premises, and benefiting from ISO 17025 accreditation, ISO 13485 certification and FDA registration, we have a proven track record in the development and large-scale manufacture of PCR and LAMP molecular assays and Immunoassays.

Footer Menu

Latest news and blogs

<img width="150" height="150" src="https://www.biofortuna.com/wp-content/uploads/2022/08/outosurce-blog-150x150.jpg" class="attachment-boc_thumb size-boc_thumb wp-post-image" alt="" title="Ten reasons to outsource assay manufacture" loading="lazy" />

Ten reasons to outsource assay manufacture

24th August 2022

<img width="150" height="150" src="https://www.biofortuna.com/wp-content/uploads/2022/08/air-150x150.png" class="attachment-boc_thumb size-boc_thumb wp-post-image" alt="" title="Lyophilising or Air Drying. Which is better for my assay?" loading="lazy" />

Lyophilising or Air Drying. Which is better for my assay?

19th August 2022

<img width="150" height="150" src="https://www.biofortuna.com/wp-content/uploads/2022/08/assay-stablisation-blog-150x150.jpg" class="attachment-boc_thumb size-boc_thumb wp-post-image" alt="" title="Re-defining the limits of single batch assay stabilisation" loading="lazy" />

Re-defining the limits of single batch assay stabilisation

17th August 2022

Contact Info

+44 151 334 0182

info@biofortuna.com

Biofortuna Limited, 2 Tenth Avenue, Deeside Industrial Park, Deeside. CH5 2UA

Biofortuna Limited © 2022